Ambrosia Biosciences Inc.
PrivateLast Round
Series B
Mar 31, 2026
Est. Valuation
$203M
Total Funding Raised
$141M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ambrosia Biosciences Inc. is a biotechnology company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambrosia Biosciences Inc. Comparables
Compare Ambrosia Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eccogene | 89% | |
| Regor Therapeutics Group | 89% | |
| Verdiva Bio | 86% | |
Ambrosia Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 10, 2024 | ||||
| Series A | Aug 20, 2024 |
Key People
Founding team and executive leadership
Ambrosia Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B |
| Janus Henderson Group | Series B |
| Blue Owl Capital | Series B |
| Deep Track Capital | Series B |
| BVF Partners L.P. | Series A, Series B |
| Boulder Ventures | Series B, Series A |
| Samsara BioCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Presenting at the American Diabetes Association's 86th Scientific Session.
- Mar 31, 2026
Sara Clarke joins the Board of Directors.
Ambrosia Biosciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ambrosia Biosciences Inc.'s valuation, stock price, and market status.